Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 25592632

Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2015 Feb
First author
Thomas A

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2015 Feb;16(2):124-5. doi: 10.1016/S1470-2045(15)70010-0.
    note
    Source null
    related pmid
    25592633
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2015 Mar;16(3):e105. doi: 10.1016/S1470-2045(15)70095-1.
    note
    Source null
    related pmid
    25752557
    relationship
    Erratum in

Authors and identifiers

  1. name
    Thomas A
    type
    Author
  2. name
    Rajan A
    type
    Author
  3. name
    Berman A
    type
    Author
  4. name
    Tomita Y
    type
    Author
  5. name
    Brzezniak C
    type
    Author
  6. name
    Lee MJ
    type
    Author
  7. name
    Lee S
    type
    Author
  8. name
    Ling A
    type
    Author
  9. name
    Spittler AJ
    type
    Author
  10. name
    Carter CA
    type
    Author
  11. name
    Guha U
    type
    Author
  12. name
    Wang Y
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Thomas A
    type
    Author
  2. name
    Rajan A
    type
    Author
  3. name
    Berman A
    type
    Author
  4. name
    Tomita Y
    type
    Author
  5. name
    Brzezniak C
    type
    Author
  6. name
    Lee MJ
    type
    Author
  7. name
    Lee S
    type
    Author
  8. name
    Ling A
    type
    Author
  9. name
    Spittler AJ
    type
    Author
  10. name
    Carter CA
    type
    Author
  11. name
    Guha U
    type
    Author
  12. name
    Wang Y
    type
    Author
bibliography ids
  1. nci-bib-042d767cd02939143d37bef7
book metadata
content sha256
879298ede467ea258f7aafe1adb4007b4c7bdeccdb7e61ce1fe94e5b6f0dc050
document type
citation
dois
  1. 10.1016/S1470-2045(14)71181-7
electronic publication date
display
2015 Jan 13
precision
day
year
2015
evidence scope
bibliographic_metadata_only
id
pubmed:25592632
immutable id
pubmed:25592632@879298ede467ea258f7aafe1adb4007b4c7bdeccdb7e61ce1fe94e5b6f0dc050
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
2
name
The Lancet. Oncology
nlm unique id
100957246
pages
177-86
volume
16
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2015 Feb;16(2):124-5. doi: 10.1016/S1470-2045(15)70010-0.
    note
    Source null
    related pmid
    25592633
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2015 Mar;16(3):e105. doi: 10.1016/S1470-2045(15)70095-1.
    note
    Source null
    related pmid
    25752557
    relationship
    Erratum in
outcomes validated
false
pmid
25592632
provenance
batch id
863b068fe5a07222af6a
provider
NCBI PubMed ESummary
record sha256
0fd6ddd60b3ddb9e83af7102fdf384d4cfb73ffb0e9927b7f16f5313174f877f
response sha256
80b1cc99e93fcfceb3e1b12ea433c615b032a2db13a615db7a6e9382c17c5034
retrieved at
2026-09-09T23:47:07.648963+00:00
publication date
display
2015 Feb
precision
month
year
2015
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Research Support, N.I.H., Extramural
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/25592632/
title
Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial.

Preserved source evidence · Not medical advice